Annual Gross Margin
82.52%
+3.05%+3.84%
31 December 2023
Summary:
Xeris Biopharma Holdings annual gross profit margin is currently 82.52%, with the most recent change of +3.05% (+3.84%) on 31 December 2023. During the last 3 years, it has risen by +28.17% (+51.83%). XERS annual gross margin is now -17.26% below its all-time high of 99.74%, reached on 31 December 2017.XERS Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
74.95%
-8.84%-10.55%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly gross profit margin is currently 74.95%, with the most recent change of -8.84% (-10.55%) on 30 September 2024. Over the past year, it has dropped by -8.08% (-9.73%). XERS quarterly gross margin is now -28.98% below its all-time high of 105.53%, reached on 31 December 2018.XERS Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.8% | -9.7% |
| 3 y3 years | +51.8% | +5.7% |
| 5 y5 years | - | - |
XERS Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +51.8% | -12.1% | +5.7% |
| 5 y | 5 years | at high | +100.7% | -12.1% | +1202.2% |
| alltime | all time | -17.3% | +100.7% | -29.0% | +1202.2% |
Xeris Biopharma Holdings Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 74.95%(-10.6%) |
| June 2024 | - | 83.79%(-1.8%) |
| Mar 2024 | - | 85.31%(+2.8%) |
| Dec 2023 | 82.52%(+3.8%) | 82.95%(-0.1%) |
| Sept 2023 | - | 83.03%(+3.6%) |
| June 2023 | - | 80.12%(-4.6%) |
| Mar 2023 | - | 83.98%(+3.7%) |
| Dec 2022 | 79.47%(+8.7%) | 81.02%(-1.6%) |
| Sept 2022 | - | 82.30%(+1.6%) |
| June 2022 | - | 80.99%(+13.1%) |
| Mar 2022 | - | 71.58%(-7.3%) |
| Dec 2021 | 73.14% | 77.19%(+8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | 70.89%(+14.3%) |
| June 2021 | - | 62.01%(-20.2%) |
| Mar 2021 | - | 77.72%(+44.5%) |
| Dec 2020 | 54.35%(+32.2%) | 53.77%(-23.1%) |
| Sept 2020 | - | 69.89%(+94.6%) |
| June 2020 | - | 35.92%(-628.2%) |
| Mar 2020 | - | -6.80%(-148.6%) |
| Dec 2019 | 41.11%(-58.8%) | 14.00%(-86.7%) |
| Dec 2018 | - | 105.53%(+25.6%) |
| Mar 2018 | - | 84.03%(-15.4%) |
| Dec 2017 | 99.74%(+0.5%) | - |
| June 2017 | - | 99.29% |
| Dec 2016 | 99.26% | - |
FAQ
- What is Xeris Biopharma Holdings annual gross profit margin?
- What is the all time high annual gross margin for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual gross margin year-on-year change?
- What is Xeris Biopharma Holdings quarterly gross profit margin?
- What is the all time high quarterly gross margin for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly gross margin year-on-year change?
What is Xeris Biopharma Holdings annual gross profit margin?
The current annual gross margin of XERS is 82.52%
What is the all time high annual gross margin for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual gross profit margin is 99.74%
What is Xeris Biopharma Holdings annual gross margin year-on-year change?
Over the past year, XERS annual gross profit margin has changed by +3.05% (+3.84%)
What is Xeris Biopharma Holdings quarterly gross profit margin?
The current quarterly gross margin of XERS is 74.95%
What is the all time high quarterly gross margin for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly gross profit margin is 105.53%
What is Xeris Biopharma Holdings quarterly gross margin year-on-year change?
Over the past year, XERS quarterly gross profit margin has changed by -8.08% (-9.73%)